| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $38.1M | +38.4% |
| Cost of Revenue | $34.0M | +34.4% |
| Gross Profit | $4.1M | +84.6% |
| R&D Expense | $22.3M | +38.5% |
| SG&A Expense | $40.8M | -36.8% |
| Operating Income | -$59.0M | +49.6% |
| Income Tax | $0 | — |
| Net Income | -$119.9M | +3.3% |
| EPS (Basic) | -$14.14 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $937K | -90.9% |
| Accounts Receivable | $2.3M | -25.9% |
| Inventory | $6.8M | +61.9% |
| Current Assets | $18.8M | -30.3% |
| Total Assets | $428.0M | +12.1% |
| Current Liabilities | $55.4M | +73.6% |
| Long-term Debt | $436.8M | +57.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$27.1M | +18.4% |
| Capital Expenditures | $82.5M | -49.2% |
| Investing Cash Flow | -$82.5M | +49.2% |
| Financing Cash Flow | $100.1M | -46.6% |
| Free Cash Flow | -$109.5M | +44.0% |
| +9.4% |
| EPS (Diluted) | -$14.14 | +9.4% |
| Total Liabilities |
| $528.5M |
| +44.2% |
| Stockholders' Equity | -$100.5M | -758.0% |